You're Training Hard, But Your Muscles Aren't Growing. Here's Why.

ACTN3 produces alpha-actinin-3, a protein that anchors the contractile machinery inside fast-twitch muscle fibers. Fast-twitch fibers are responsible for explosive movements like sprinting, jumping, and heavy lifting. Without functional ACTN3, fast-twitch fibers lose some of their structural integrity and can’t generate force as efficiently.

The X/X null variant, found in roughly 18% of people with European ancestry, means you produce no functional ACTN3 at all. Your fast-twitch fibers have a fundamentally different structure than people with at least one R allele. This doesn’t mean you’re weak. It means your nervous system has a genetic reason to favor endurance-type movements over explosive power.

If you have the X/X genotype, you likely notice that you excel at sustained efforts like distance running, cycling, or rowing, but struggle to generate explosive force in a single movement. Heavy squats and deadlifts feel harder to progress on. Your sprint times are slower than your friends with R alleles. This isn’t a training failure. It’s your genetic fiber type expression.

PPARGC1A produces PGC-1 alpha, the master regulator that tells your cells to build new mitochondria in response to aerobic exercise. Mitochondria are your cellular power plants. More mitochondria means more ATP production, which means more energy for training, recovery, and daily life. When you do aerobic exercise, PGC-1 alpha wakes up and signals your cells to manufacture new mitochondria.

The Ser variant of PPARGC1A, carried by roughly 35 to 40% of the population, fundamentally reduces this mitochondrial-building response. When you do the same aerobic training as someone with the Gly/Gly genotype, your body builds fewer new mitochondria. This means your VO2max improves more slowly, your lactate threshold stays lower, and your aerobic capacity gains from training are significantly smaller.

If you have the Ser variant, you’ve probably noticed that endurance training feels inefficient. You can run or cycle consistently for months and see minimal improvement in your aerobic capacity. Your heart rate doesn’t drop as much as your friends’ after the same training block. You fatigue faster in long efforts. This isn’t because you’re less dedicated. It’s because your genetics are suppressing the mitochondrial adaptation that drives aerobic improvement.

ADRB2 encodes the beta-2 adrenergic receptor, which sits on the surface of fat cells and receives the signal to release stored fat into the bloodstream during exercise or calorie deficit. When your body needs energy, epinephrine and norepinephrine (stress hormones) bind to these receptors and trigger lipolysis, the breakdown of stored fat.

The Glu27 and Arg16 variants of ADRB2, each carried by roughly 40% of the population, reduce the sensitivity of fat cells to this fat-mobilization signal. Even when your stress hormones are screaming at your fat cells to release energy, your cells respond with less vigor. Your fat cells are biochemically resistant to mobilization. This means during a calorie deficit, your body mobilizes less fat for energy, which often means greater muscle loss and a slower metabolic adaptation.

If you carry the Glu27 or Arg16 variants, you’ve probably experienced frustrating body composition resistance. You can cut calories aggressively, train hard, and see minimal fat loss for weeks. Meanwhile, you’re losing muscle alongside the fat because your body is preferentially using muscle for energy instead of mobilizing its stored fat reserves. This is not a discipline problem. It’s a receptor sensitivity problem.

VDR encodes the vitamin D receptor, a protein that allows your muscle cells to respond to active vitamin D (calcitriol). Vitamin D binds to this receptor and activates genes involved in muscle protein synthesis, calcium signaling, and muscle fiber growth. Without a responsive VDR, even high levels of circulating vitamin D can’t trigger these adaptations.

The BsmI and FokI variants of VDR, found in roughly 30 to 50% of the population depending on the specific variant, reduce the efficiency of this receptor’s function. Your muscle cells become less responsive to vitamin D signaling, which impairs both muscle protein synthesis and calcium handling during contraction and recovery. This reduces your capacity to repair damaged muscle fibers after training and slows your progress from workout to workout.

If you have VDR variants, you’ve likely noticed slow recovery from training. Your muscles feel sore longer. Your strength gains plateau more frequently. Even when your serum vitamin D levels are technically normal, your muscles aren’t responding optimally to that vitamin D. You might supplement with D and still see slow muscle adaptation because the problem isn’t vitamin D availability; it’s receptor sensitivity.

SOD2 encodes superoxide dismutase 2, an antioxidant enzyme that lives inside mitochondria and neutralizes free radicals produced during energy production. During intense training, your mitochondria produce massive amounts of reactive oxygen species (ROS). SOD2 is your first line of defense against oxidative damage to your muscle fibers.

The Val16Ala variant of SOD2, carried by roughly 40% of the population in homozygous form, reduces the expression of this protective enzyme. Your mitochondria produce the same amount of free radicals during training, but you have less enzymatic capacity to neutralize them, leaving more oxidative damage to your muscle tissue. This increases exercise-induced muscle damage (DOMS), slows protein synthesis, and extends recovery time between training sessions.

If you have the Ala/Ala genotype, you’ve probably experienced severe, prolonged soreness after new training stimuli. Your muscles take longer to recover. You fatigue faster during back-to-back training days. You might feel unusually sore even from workouts that shouldn’t be that demanding. This is oxidative stress accumulation, not weakness.

MTHFR encodes methylenetetrahydrofolate reductase, an enzyme that converts folate into its active form, methylfolate, which is required for converting homocysteine into methionine. This process is critical for red blood cell production, energy metabolism, and vascular function. Efficient folate metabolism means lower homocysteine, better oxygen transport, and improved blood flow during exercise.

The C677T variant of MTHFR, carried by roughly 40% of the population with European ancestry, reduces enzyme efficiency by 30 to 40%. Your homocysteine levels remain elevated even with adequate folate intake, which impairs vascular function during exercise and reduces your aerobic capacity gains from training. Your red blood cells are less efficient at carrying oxygen. Your blood vessels are less responsive to training-induced adaptations.

If you have the C677T variant, you’ve likely experienced lower aerobic capacity than expected for your training volume. Your VO2max improvements lag behind your friends with the normal genotype. You might feel short of breath earlier in long efforts. You can eat a diet high in folate and still have functionally low circulating folate because your body can’t convert it efficiently into usable forms.